Effective use of AI in the life sciences: BioLizard weighs in at Knowledge for Growth
Ghent, 16th June 2023. At the beginning of June, we took part in Knowledge for Growth, an event where industry leaders and visionaries come together to shape the future of life sciences. At this event, Volodimir Olexiouk, our Director of Scientific Engagement and AI...
Creating a user-friendly and informative app that empowers colorectal cancer patients
We are incredibly proud of our collaboration with the Pierre Fabre Group in developing a user-friendly and informative app that empowers colorectal cancer patients to take control of their health. From concept to launch, our team has been dedicated to creating an app...
BioLizard partners with Scaler8’s explore programme to unlock novel US market opportunities
Ghent, 17th May 2023. We are pleased to announce our partnership with Scaler8‘s Explore Programme. This collaboration marks a significant milestone for BioLizard as it sets its sights on expanding its reach and exploring new international markets. Scaler8,...
BioLizard strengthens board with appointment of three new members
Ghent, 25th April 2023. BioLizard announced today the appointment of three independent members to the board of directors. Caroline Vanovermeire, André van de Sande, and Laurie Heilmann join company co-founder, Wim Van Criekinge, Novalis fund...